Concepedia

Daniel Alencar Rodrigues

DA

Statistics

Publications

10

Citations

366

H-Index

10

Active since

2012

Affiliations

Universidade Federal do Rio de Janeiro(Current)

Universidade Federal Rural do Rio de Janeiro

Royal College of Surgeons in Ireland

Universidade Federal do Rio Grande do Sul

Daniel Alencar Rodrigues is an author at Universidade Federal do Rio de Janeiro specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2012–2023

10

Publications

10

Design, Synthesis, and Pharmacological Evaluation of Novel<i>N</i>-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors

Daniel Alencar Rodrigues, Guilherme Álvaro Ferreira‐Silva, Ana Carolina S. Ferreira et al. · Journal of Medicinal Chemistry · 2015 · 110 citations · Full text

, , +15

Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases

Daniel Alencar Rodrigues, Fernanda S. Sagrillo, Carlos Alberto Manssour Fraga · Pharmaceuticals · 2019 · 78 citations · Full text

, , +13

Design, Synthesis, and Pharmacological Evaluation of First‐in‐Class Multitarget <i>N</i>‐Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors

Daniel Alencar Rodrigues, Fabiana Sélos Guerra, Fernanda S. Sagrillo et al. · ChemMedChem · 2020 · 43 citations

, , +15

Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexes

Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra et al. · International Journal of Biological Macromolecules · 2015 · 38 citations · Full text

, , +16

Advances in the Design and Development of PROTAC-mediated HDAC Degradation

Daniel Alencar Rodrigues, Andrew Roe, Darren M. Griffith et al. · Current Topics in Medicinal Chemistry · 2021 · 21 citations · Full text

, , +17

1–5 of 10